Bilateral herpetic keratitis after bilateral intravitreal bevacizumab for exudative macular degeneration

Angeline M. Derham, Eric Chen, Vatinee Y. Bunya, Ronan E. O'Malley

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Purpose: To report a case of bilateral herpetic epithelial keratitis after bilateral intravitreal bevacizumab injections for the treatment of exudative age-related macular degeneration. Methods: A 66-year-old man with diabetes and an extensive history of bilateral anti-vascular endothelial growth factor treatments for exudative age-related macular degeneration received an intravitreal bevacizumab injection in the right eye and triple therapy (bevacizumab, photodynamic therapy, and triamcinolone acetonide) in the left eye. After 4 days, he presented with pain, photophobia, tearing, and decreased vision in both eyes. Slit-lamp examination revealed bilateral dendritic epithelial lesions with terminal bulbs, and he was diagnosed with bilateral herpes simplex epithelial keratitis. Results: The patient was treated with ganciclovir ophthalmic ointment and oral acyclovir with resolution of signs and symptoms. Conclusions: To our knowledge, this is the first documented account of bilateral herpetic epithelial keratitis after bilateral intravitreal bevacizumab injections.

Original languageEnglish (US)
Pages (from-to)878-879
Number of pages2
JournalCornea
Volume36
Issue number7
DOIs
StatePublished - 2017

Keywords

  • Age-related macular degeneration
  • Bevacizumab
  • Diabetes mellitus
  • Herpes simplex epithelial keratitis
  • Intravitreal injection

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Bilateral herpetic keratitis after bilateral intravitreal bevacizumab for exudative macular degeneration'. Together they form a unique fingerprint.

Cite this